Monash IVF Group Overview
- Status
-
Public
- Employees
-
547
- Stock Symbol
-
MVF
- Investments
-
9
- Share Price
-
$0.51
- (As of Tuesday Closing)
Monash IVF Group General Information
Description
Monash IVF Group Ltd is a provider of fertility services and a driving force in the development of Assisted Reproductive Technologies (ART) and tertiary-level prenatal diagnostics, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates through two main segments: Australia IVF and Ultrasound, which provides Assisted Reproductive Services, Ultrasound and other related services, and other related services. Its business includes KL Fertility, Monash IVF, Monash IVF KPJ Johor, Monash Ultrasound for Women and Repromed, among others. The majority of revenue is generated from the Australia IVF and Ultrasound segment.
Contact Information
Website
www.monashivfgroup.com.auCorporate Office
- Level 1
- 510 Church Street
- Cremorne, Victoria 3121
- Australia
Corporate Office
- Level 1
- 510 Church Street
- Cremorne, Victoria 3121
- Australia
Monash IVF Group Stock Performance
As of 17-Nov-2026, Monash IVF Group’s stock price is $0.51. Its current market cap is $199M with 390M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.51 | $0.49 | $0.38 - $0.60 | $199M | 390M | 745K | $0.01 |
Monash IVF Group Financials Summary
As of 30-Jun-2026, Monash IVF Group has a trailing 12-month revenue of $183M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 327,633 | 327,633 | 281,690 | 412,902 |
| Revenue | 182,539 | 182,539 | 175,935 | 167,085 |
| EBITDA | 29,475 | 29,475 | 42,335 | 8,673 |
| Net Income | 5,030 | 5,030 | 16,181 | (4,277) |
| Total Assets | 352,596 | 352,596 | 321,766 | 339,861 |
| Total Debt | 137,375 | 137,375 | 117,594 | 90,481 |
Monash IVF Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Monash IVF Group Comparisons
Industry
Financing
Details
Monash IVF Group Competitors (3)
One of Monash IVF Group’s 3 competitors is Virtus Health, a Private Equity-Backed company based in Greenwich, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Virtus Health | Private Equity-Backed | Greenwich, Australia | ||||
| IVF Australia | Private Equity-Backed | Greenwich, Australia | ||||
| Melbourne IVF | Private Equity-Backed | East Melbourne, Australia |
Monash IVF Group Patents
Monash IVF Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019902204-A0 | Methods of predicting endometrial receptivity | Inactive | 25-Jun-2019 | ||
| AU-2020302958-A1 | Methods of predicting endometrial receptivity | Inactive | 25-Jun-2019 | ||
| CA-3145010-A1 | Methods of predicting endometrial receptivity | Pending | 25-Jun-2019 | ||
| EP-3990663-A1 | Methods of predicting endometrial receptivity | Inactive | 25-Jun-2019 | ||
| EP-3990663-A4 | Methods of predicting endometrial receptivity | Inactive | 25-Jun-2019 | C12Q1/6876 |
Monash IVF Group Signals
Monash IVF Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Monash IVF Group Investments & Acquisitions (9)
Monash IVF Group’s most recent deal was a Merger/Acquisition with Fertility North for . The deal was made on 04-Mar-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Fertility North | 04-Mar-2024 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Symex Labs | 01-Jan-2024 | Early Stage VC | Monitoring Equipment | ||
| PIVET Medical Centre | 27-May-2023 | Merger/Acquisition | Clinics/Outpatient Services | ||
| ART Associates Queensland #2 | 01-Jul-2022 | Merger/Acquisition | Other Healthcare Services | ||
| Fertility Solutions | 10-Jul-2019 | Merger/Acquisition | Clinics/Outpatient Services |
Monash IVF Group ESG
Risk Overview
Risk Rating
Updated March, 31, 2026
23.75 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,271
Rank
Percentile
Healthcare
Industry
of 614
Rank
Percentile
Medical Services
Subindustry
of 100
Rank
Percentile
Monash IVF Group Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Fertility Solutions | Buderim, Australia | 2007 | |
| Fertility North | Joondalup, Australia | 2002 | |
| Sydney Ultrasound for Women | Bella Vista, Australia | 1986 | |
| Kl Fertility Centre | Kuala Lumpur, Malaysia |
Monash IVF Group FAQs
-
Where is Monash IVF Group headquartered?
Monash IVF Group is headquartered in Cremorne, Australia.
-
What is the size of Monash IVF Group?
Monash IVF Group has 547 total employees.
-
What industry is Monash IVF Group in?
Monash IVF Group’s primary industry is Clinics/Outpatient Services.
-
Is Monash IVF Group a private or public company?
Monash IVF Group is a Public company.
-
What is Monash IVF Group’s stock symbol?
The ticker symbol for Monash IVF Group is MVF.
-
What is the current stock price of Monash IVF Group?
As of 17-Nov-2026 the stock price of Monash IVF Group is $0.51.
-
What is the current market cap of Monash IVF Group?
The current market capitalization of Monash IVF Group is $199M.
-
What is Monash IVF Group’s current revenue?
The trailing twelve month revenue for Monash IVF Group is $183M.
-
Who are Monash IVF Group’s competitors?
Virtus Health, IVF Australia, and Melbourne IVF are competitors of Monash IVF Group.
-
What is Monash IVF Group’s annual earnings per share (EPS)?
Monash IVF Group’s EPS for 12 months was $0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process